ROT-TDS, Neupro 8 mg/24 h transdermal patch, Neupro 8 mg/24 h transdermal patch clinical trials

Comparative, randomized, open, crossover clinical trial to investigate adhesiveness of a newly developed Rotigotine 12 mg/24 h transdermal patch in patients with Parkinson’s disease

This study is looking at how well a new patch for Parkinson's disease sticks to the skin compared to an existing patch. It's an early-stage trial focusing on how well the patches stay on for nearly a full day.